3-(2-(2-chlorobenzyl)-1H-benzo[d]imidazol-6-yl)-1-((1r,4r)-4-(1-(3-methoxypropyl)piperidin-4-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

InChIKey	`ZRTDGPKHIJCQNA-UHFFFAOYSA-N`
Compound Name	3-(2-(2-chlorobenzyl)-1H-benzo[d]imidazol-6-yl)-1-((1r,4r)-4-(1-(3-methoxypropyl)piperidin-4-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
Canonical SMILES	`COCCCN1CCC(C2CCC(n3nc(-c4ccc5nc(Cc6ccccc6Cl)[nH]c5c4)c4c(N)ncnc43)CC2)CC1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	2
Pfam Stratification	Cross-Family
Avg pChEMBL	7.26
Source	TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P04626	ERBB2	Homo sapiens	Human	PF00757 PF14843 PF07714 PF01030 PF21314	7.3	pIC50	TTD_MultiTarget
P06729	CD2	Homo sapiens	Human	PF05790 PF07686	7.3	pIC50	TTD_MultiTarget